Vor Biopharma Inc.VOR

時価総額

$4551.8万

PER

	2021年 12月31日	2022年 12月31日
Net loss	-69	-92
Depreciation	1	3
Non-cash lease expense	3	6
Stock-based compensation	4	11
Other	0	-0
Operating lease liability	-3	-13
Prepaid expenses and other current assets	6	-0
Accounts payable and accrued liabilities	0	1
Other assets	1	1
Net cash used in operating activities	-69	-85
Purchases of marketable securities	-	123
Proceed from maturities of marketable securities	-	38
Purchases of property and equipment	4	8
Net cash used in investing activities	-92	-94
Proceeds from issuance of redeemable convertible preferred stock	45	-
Proceeds from Issuance Initial Public Offering	189	-
Payment of initial public offering costs	2	-
Proceeds From Issuance Initial Public Offering And Concurrent Private Placement	-	112
Proceeds from Issuance of Common Stock	-	4
Proceeds from stock option exercises and issuance of common stock under ESPP	-	1
Net cash provided by financing activities	233	117
Net (decrease) increase in cash, cash equivalents and restricted cash equivalents	72	-62
Lease Incentive Paid By Landlord	-	8
Operating right-of-use assets and operating lease liability recorded upon lease commencement	0	23
Capital Expenditures Incurred but Not yet Paid	0	0
Financing costs associated with the sale of common stock included in accounts payable and accrued expenses	-	1
Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Closing Of Initial Public Offering	153	-